Analysis of prognostic factors on trifluridine-tipiracil plus bevacizumab treatment in metastatic colorectal cancer: A retrospective real-world analysis

被引：0
|
作者：
Onishi, M. [1 ]
Hirose, T. [1 ]
Shoji, H. [1 ]
Okita, N. T. [1 ]
Hirano, H. [1 ]
Takashima, A. [1 ]
Kato, K. [1 ]
机构：
[1] NCCH Natl Canc Ctr Hosp, Dept Gastrointestinal Med Oncol, Tsukiji Campus,Chuo Ku, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.121
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
99P
引用
收藏
页码：S1441 / S1441
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of trifluridine/tipiracil and bevacizumab (FTD/TPI plus BEV) in patients with metastatic colorectal cancer (mCRC) in real-world practice.
    Lago, Nieves Martinez
    Reboredo, Margarita
    Gonzalez Gomez, Borja
    de Frutos Gonzalez, Belen
    Riesco Martinez, Maria Carmen
    Antonilli, Paula Carla
    Lopez Alfonso, Ana
    Gallardo Martin, Elena
    Fernandez Montes, Ana Fernandez
    Cabezon-Gutierrez, Luis
    Castineira, Antia Cousillas
    Ferreiro, Reyes
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 204 - 204
  • [32] The Efficacy and Safety of Trifluridine/Tipiracil Treatment for Elderly Patients With Metastatic Colorectal Cancer in a Real-world Setting
    Shibutani, Masatsune
    En, Wang
    Okazaki, Yuki
    Kashiwagi, Shinichiro
    Fukuoka, Tatsunari
    Iseki, Yasuhito
    Hirakawa, Kosei
    Ohira, Masaichi
    ANTICANCER RESEARCH, 2021, 41 (12) : 6211 - 6216
  • [33] The safety and efficacy of trifluridine-tipiracil for metastatic colorectal cancer: A pharmacy perspective
    Chan, Betty M.
    Hochster, Howard S.
    Lenz, Heinz-Josef
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (06) : 339 - 348
  • [34] Trifluridine/tipiracil plus bevacizumab (FTD/TPI plus BEV) and trifluridine/tipiracil (FTD/TPI) monotherapy in metastatic colorectal cancer (mCRC): Results of a meta-analysis.
    Yoshino, Takayuki
    Taieb, Julien
    Andre, Thierry
    Kuboki, Yasutoshi
    Pfeiffer, Per
    Kumar, Amit
    Hochster, Howard S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [35] Benefit of adding bevacizumab to trifluridine/tipiracil in different prognostic groups of metastatic colorectal cancer: A Portuguese exploratory analysis
    Roque, R.
    Coelho, A.
    Brasil, S.
    Santos, R. Antunes
    Santos, L.
    Gomes, I.
    Fraga, T.
    Caetano, A.
    Paulo, J.
    Bonito, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S121 - S122
  • [36] Prognostic impact and risk factors of severe neutropenia in the early phase of treatment with trifluridine-tipiracil for metastatic colorectal cancer patients: a single-center retrospective study
    Omori, Yoshiro
    Matsukuma, Satoshi
    Kawa, Mikiko
    Ishimitsu, Kazuki
    Kawaoka, Toru
    Akiyama, Norio
    Tokuno, Kazuhisa
    Fujita, Yuji
    Sato, Shinya
    Yamamoto, Shigeru
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2025, 40 (01)
  • [37] Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients
    Takahashi, Toshiaki
    Shigeyasu, Kunitoshi
    Kondo, Yoshitaka
    Takeda, Sho
    Umeda, Hibiki
    Moriwake, Kazuya
    Kayano, Masashi
    Sakurai, Yuya
    Nakamura, Shunsuke
    Takahashi, Masafumi
    Nitta, Kaori
    Yoshida, Kazuhiro
    Matsumi, Yuki
    Michiue, Hiroyuki
    Yamamoto, Hideki
    Kishimoto, Hiroyuki
    Teraishi, Fuminori
    Shoji, Ryohei
    Kanaya, Nobuhiko
    Kashima, Hajime
    Kakiuchi, Yoshihiko
    Kuroda, Shinji
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    BMC CANCER, 2025, 25 (01)
  • [38] A real-world comparison of trifluridine/tipiracil and regorafenib in refractory metastatic colorectal cancer in the United States
    Nevala-Plagemann, Christopher Duane
    Ying, Jian
    Sama, Shashank
    Florou, Vaia
    Haaland, Benjamin
    Garrido-Laguna, Ignacio
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [39] An Exploration of Trifluridine/Tipiracil Monotherapy and in Combination With Bevacizumab or Immune Checkpoint Inhibitors for Patients With Metastatic Colorectal Cancer: A Real-World Study
    Nie, Caiyun
    Xu, Weifeng
    Chen, Beibei
    Lv, Huifang
    Wang, Jianzheng
    Liu, Yingjun
    He, Yunduan
    Wang, Saiqi
    Zhao, Jing
    Chen, Xiaobing
    CLINICAL COLORECTAL CANCER, 2023, 22 (01) : 76 - 84
  • [40] Sequential Treatment of Metastatic Colorectal Cancer in Taiwan: Real-World Evidence From Regorafenib and Trifluridine/Tipiracil Use
    Chang, Ya-Wen
    Kuo, Chun-Nan
    Chang, Chia-Lun
    Hsu, Jason C.
    Ko, Yu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2025,
12345